Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
581
datasets available to search
ShareScore release 0.9.0
Dataset results
581 results for “Eosinophils”
Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis
ClinicalTrials.gov study NCT02227836. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years
ClinicalTrials.gov study NCT00538434. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level
ClinicalTrials.gov study NCT04133909. IPD Sharing: YES. Countries: 26. Publications: 1.
Benralizumab for Eosinophilic Gastritis (BEGS)
ClinicalTrials.gov study NCT03473977. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma
ClinicalTrials.gov study NCT01312961. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
ClinicalTrials.gov study NCT00123630. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Mepolizumab on Severe Eosinophilic Asthma
ClinicalTrials.gov study NCT04641741. IPD Sharing: NO. Countries: 1. Publications: 9.
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype
ClinicalTrials.gov study NCT04718389. IPD Sharing: YES. Countries: 21. Publications: 0.
Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients
ClinicalTrials.gov study NCT02654145. IPD Sharing: YES. Countries: 9. Publications: 1.
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
ClinicalTrials.gov study NCT00728481. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
ClinicalTrials.gov study NCT02281318. IPD Sharing: YES. Countries: 19. Publications: 7.
A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
ClinicalTrials.gov study NCT04718103. IPD Sharing: YES. Countries: 11. Publications: 2.
A Study of Benralizumab in Patients With Eosinophilic Esophagitis
ClinicalTrials.gov study NCT04543409. IPD Sharing: YES. Countries: 12. Publications: 1.
Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
ClinicalTrials.gov study NCT04719832. IPD Sharing: YES. Countries: 12. Publications: 2.
Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis
ClinicalTrials.gov study NCT00638456. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis
ClinicalTrials.gov study NCT02020889. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases
ClinicalTrials.gov study NCT04765722. IPD Sharing: NO. Countries: 1. Publications: 10.
A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab
ClinicalTrials.gov study NCT04159519. IPD Sharing: UNDECIDED. Countries: 4. Publications: 2.
An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils
ClinicalTrials.gov study NCT02501629. IPD Sharing: Not stated. Countries: 17. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
ClinicalTrials.gov study NCT01285323. IPD Sharing: Not stated. Countries: 15. Publications: 7.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.